TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 3nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 5nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 7nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 8nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 5.10nM ΔG°: -11.2kcal/mole EC50: 8.64nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 9nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 4.30nM ΔG°: -11.3kcal/mole EC50: 14nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 14nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 10nM ΔG°: -10.8kcal/mole EC50: 15nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 15nM ΔG°: -10.6kcal/mole EC50: 19nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 14nM ΔG°: -10.6kcal/mole EC50: 23nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 33nM ΔG°: -10.1kcal/mole EC50: 41nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 57nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 70nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 71nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 48nM ΔG°: -9.88kcal/mole EC50: 81nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 87nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 93nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 118nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 128nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 50nM ΔG°: -9.85kcal/mole EC50: 130nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 146nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 180nM ΔG°: -9.10kcal/mole EC50: 150nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 152nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 165nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 185nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 94nM ΔG°: -9.48kcal/mole EC50: 220nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 242nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 70nM ΔG°: -9.66kcal/mole EC50: 250nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 200nM ΔG°: -9.04kcal/mole EC50: 270nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 274nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 344nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 365nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 370nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 378nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 394nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 420nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 435nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 446nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 499nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 500nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 508nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 509nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 561nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 570nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 586nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 593nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 840nM ΔG°: -8.20kcal/mole EC50: 600nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 604nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid type B receptor subunit 2(Rattus norvegicus)
Abbvie Deutschland
US Patent
Abbvie Deutschland
US Patent
Affinity DataEC50: 628nMAssay Description:The composition of the assay mixtures [in a final volume of 200 μL in 96-well U-bottom plates (Greiner) was as follows: 50 mM Tris-HCl buffer, p...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)